Molecular Advances in Vaginitis Care: The Latest from the Aptima BV & CV/TV Assay Trial

About this webinar

Vaginitis remains one of the most common causes of clinical presentation in women’s health, yet diagnosis and management can be complex due to overlapping symptoms, mixed infections, and variability in testing approaches. For many laboratories, moving from selective or symptomatic testing to a more comprehensive, routine approach presents both operational and clinical challenges.

Join Hologic for an insightful session exploring how laboratories can transition from need-based testing to a streamlined, routine diagnostic pathway for vaginitis. This webinar will provide an update on the Aptima BV and CV/TV assay evaluation, highlighting how molecular testing can support improved diagnostic accuracy, workflow efficiency, and patient management.

This live webinar will explore:

• Understanding the diagnostic gap: why traditional approaches to vaginitis testing may fall short in identifying causative pathogens
• Moving towards comprehensive testing: the clinical and operational benefits of routine, syndromic molecular testing
• Trial insights: key learnings and performance updates from the Aptima BV and CV/TV assay evaluation
• Implementation considerations: integrating comprehensive vaginitis testing into existing laboratory workflows
• Impact on patient care: supporting timely, accurate diagnosis to guide appropriate treatment decisions
• Future outlook: the evolving role of molecular diagnostics in women’s health and implications for laboratory services